Watson Biology (300142.SZ) released its first quarter performance, with a net profit attributable to shareholders of 2.6462 million yuan, a decrease of 81.27%.

The Zhitong Finance APP reported that Watson Biotech (300142.SZ) released its first quarter report for 2025, with the company's operating income at 462 million yuan, a decrease of 22.93% year-on-year. The net profit attributable to the shareholders of the listed company was 2.6462 million yuan, a decrease of 81.27% year-on-year. The net loss attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 11.4902 million yuan. The basic earnings per share was 0.0017 yuan.